| 000 | 01753 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515030920.0 | ||
| 264 | 0 | _c20060831 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/01.CCM.0000227173.13497.56 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCristofaro, Patricia A | |
| 245 | 0 | 0 |
_aWAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. _h[electronic resource] |
| 260 |
_bCritical care medicine _cAug 2006 |
||
| 300 |
_a2188-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAscitic Fluid _xmetabolism |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEstrogen Receptor beta _xagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
| 650 | 0 | 4 | _aListeria monocytogenes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNaphthols _xpharmacology |
| 650 | 0 | 4 |
_aNeutropenia _xcomplications |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aShock, Septic _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aOpal, Steven M | |
| 700 | 1 | _aPalardy, John E | |
| 700 | 1 | _aParejo, Nicolas A | |
| 700 | 1 | _aJhung, Jhung | |
| 700 | 1 | _aKeith, James C | |
| 700 | 1 | _aHarris, Heather A | |
| 773 | 0 |
_tCritical care medicine _gvol. 34 _gno. 8 _gp. 2188-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.CCM.0000227173.13497.56 _zAvailable from publisher's website |
| 999 |
_c16351512 _d16351512 |
||